List of Tables
Table 1. Global Hemophilia Gene Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Hemophilia A
Table 3. Key Players of Hemophilia B
Table 4. Global Hemophilia Gene Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Hemophilia Gene Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Hemophilia Gene Therapy Market Size by Region (US$ Million), 2021–2026
Table 7. Global Hemophilia Gene Therapy Market Share by Region (2021–2026)
Table 8. Global Hemophilia Gene Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Hemophilia Gene Therapy Market Share by Region (2027–2032)
Table 10. Hemophilia Gene Therapy Market Trends
Table 11. Hemophilia Gene Therapy Market Drivers
Table 12. Hemophilia Gene Therapy Market Challenges
Table 13. Hemophilia Gene Therapy Market Restraints
Table 14. Global Hemophilia Gene Therapy Revenue by Players (US$ Million), 2021–2026
Table 15. Global Hemophilia Gene Therapy Market Share by Players (2021–2026)
Table 16. Global Top Hemophilia Gene Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Hemophilia Gene Therapy Revenue, 2025
Table 17. Ranking of Global Top Hemophilia Gene Therapy Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Hemophilia Gene Therapy Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Hemophilia Gene Therapy, Headquarters and Area Served
Table 20. Global Key Players of Hemophilia Gene Therapy, Products and Applications
Table 21. Global Key Players of Hemophilia Gene Therapy, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Hemophilia Gene Therapy Market Size by Type (US$ Million), 2021–2026
Table 24. Global Hemophilia Gene Therapy Revenue Market Share by Type (2021–2026)
Table 25. Global Hemophilia Gene Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Hemophilia Gene Therapy Revenue Market Share by Type (2027–2032)
Table 27. Global Hemophilia Gene Therapy Market Size by Application (US$ Million), 2021–2026
Table 28. Global Hemophilia Gene Therapy Revenue Market Share by Application (2021–2026)
Table 29. Global Hemophilia Gene Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Hemophilia Gene Therapy Revenue Market Share by Application (2027–2032)
Table 31. North America Hemophilia Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Hemophilia Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 33. North America Hemophilia Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Hemophilia Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Hemophilia Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Hemophilia Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Hemophilia Gene Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Hemophilia Gene Therapy Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Hemophilia Gene Therapy Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Hemophilia Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Hemophilia Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Hemophilia Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Hemophilia Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Hemophilia Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Hemophilia Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 46. Spark Therapeutics Company Details
Table 47. Spark Therapeutics Business Overview
Table 48. Spark Therapeutics Hemophilia Gene Therapy Product
Table 49. Spark Therapeutics Revenue in Hemophilia Gene Therapy Business (US$ Million), 2021–2026
Table 50. Spark Therapeutics Recent Development
Table 51. Ultragenyx Company Details
Table 52. Ultragenyx Business Overview
Table 53. Ultragenyx Hemophilia Gene Therapy Product
Table 54. Ultragenyx Revenue in Hemophilia Gene Therapy Business (US$ Million), 2021–2026
Table 55. Ultragenyx Recent Development
Table 56. Shire PLC Company Details
Table 57. Shire PLC Business Overview
Table 58. Shire PLC Hemophilia Gene Therapy Product
Table 59. Shire PLC Revenue in Hemophilia Gene Therapy Business (US$ Million), 2021–2026
Table 60. Shire PLC Recent Development
Table 61. Sangamo Therapeutics Company Details
Table 62. Sangamo Therapeutics Business Overview
Table 63. Sangamo Therapeutics Hemophilia Gene Therapy Product
Table 64. Sangamo Therapeutics Revenue in Hemophilia Gene Therapy Business (US$ Million), 2021–2026
Table 65. Sangamo Therapeutics Recent Development
Table 66. Bioverativ Company Details
Table 67. Bioverativ Business Overview
Table 68. Bioverativ Hemophilia Gene Therapy Product
Table 69. Bioverativ Revenue in Hemophilia Gene Therapy Business (US$ Million), 2021–2026
Table 70. Bioverativ Recent Development
Table 71. BioMarin Company Details
Table 72. BioMarin Business Overview
Table 73. BioMarin Hemophilia Gene Therapy Product
Table 74. BioMarin Revenue in Hemophilia Gene Therapy Business (US$ Million), 2021–2026
Table 75. BioMarin Recent Development
Table 76. uniQure Company Details
Table 77. uniQure Business Overview
Table 78. uniQure Hemophilia Gene Therapy Product
Table 79. uniQure Revenue in Hemophilia Gene Therapy Business (US$ Million), 2021–2026
Table 80. uniQure Recent Development
Table 81. Freeline Therapeutics Company Details
Table 82. Freeline Therapeutics Business Overview
Table 83. Freeline Therapeutics Hemophilia Gene Therapy Product
Table 84. Freeline Therapeutics Revenue in Hemophilia Gene Therapy Business (US$ Million), 2021–2026
Table 85. Freeline Therapeutics Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
Table 89. Authors List of This Report
List of Figures
Figure 1. Hemophilia Gene Therapy Picture
Figure 2. Global Hemophilia Gene Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Hemophilia Gene Therapy Market Share by Type: 2025 vs 2032
Figure 4. Hemophilia A Features
Figure 5. Hemophilia B Features
Figure 6. Global Hemophilia Gene Therapy Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Hemophilia Gene Therapy Market Share by Application: 2025 vs 2032
Figure 8. Hemophilia A Gene Therapy Case Studies
Figure 9. Hemophilia B Gene Therapy Case Studies
Figure 10. Hemophilia Gene Therapy Report Years Considered
Figure 11. Global Hemophilia Gene Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 12. Global Hemophilia Gene Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Hemophilia Gene Therapy Market Share by Region: 2025 vs 2032
Figure 14. Global Hemophilia Gene Therapy Market Share by Players in 2025
Figure 15. Global Hemophilia Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Hemophilia Gene Therapy Revenue in 2025
Figure 17. North America Hemophilia Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 18. North America Hemophilia Gene Therapy Market Share by Country (2021–2032)
Figure 19. United States Hemophilia Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. Canada Hemophilia Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Europe Hemophilia Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Hemophilia Gene Therapy Market Share by Country (2021–2032)
Figure 23. Germany Hemophilia Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. France Hemophilia Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. U.K. Hemophilia Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Italy Hemophilia Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Russia Hemophilia Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Ireland Hemophilia Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Asia-Pacific Hemophilia Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Hemophilia Gene Therapy Market Share by Region (2021–2032)
Figure 31. China Hemophilia Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Japan Hemophilia Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. South Korea Hemophilia Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Southeast Asia Hemophilia Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. India Hemophilia Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Australia & New Zealand Hemophilia Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Latin America Hemophilia Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Hemophilia Gene Therapy Market Share by Country (2021–2032)
Figure 39. Mexico Hemophilia Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Brazil Hemophilia Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Middle East & Africa Hemophilia Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Hemophilia Gene Therapy Market Share by Country (2021–2032)
Figure 43. Israel Hemophilia Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Saudi Arabia Hemophilia Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. UAE Hemophilia Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Spark Therapeutics Revenue Growth Rate in Hemophilia Gene Therapy Business (2021–2026)
Figure 47. Ultragenyx Revenue Growth Rate in Hemophilia Gene Therapy Business (2021–2026)
Figure 48. Shire PLC Revenue Growth Rate in Hemophilia Gene Therapy Business (2021–2026)
Figure 49. Sangamo Therapeutics Revenue Growth Rate in Hemophilia Gene Therapy Business (2021–2026)
Figure 50. Bioverativ Revenue Growth Rate in Hemophilia Gene Therapy Business (2021–2026)
Figure 51. BioMarin Revenue Growth Rate in Hemophilia Gene Therapy Business (2021–2026)
Figure 52. uniQure Revenue Growth Rate in Hemophilia Gene Therapy Business (2021–2026)
Figure 53. Freeline Therapeutics Revenue Growth Rate in Hemophilia Gene Therapy Business (2021–2026)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
